KFGK
RXRX icon

Keystone Financial Group (Kentucky)’s Recursion Pharmaceuticals RXRX Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.7K Sell
10,000
-6,000
-38% -$20K ﹤0.01% 559
2026
Q1 		$49.1K Buy
16,000
+2,000
+14% +$7.73K ﹤0.01% 513
2025
Q4 		$57.3K Buy
+14,000
New +$69.3K ﹤0.01% 447

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s RXRX Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) reduced its Recursion Pharmaceuticals (RXRX) stake by 38% in Q2 2026, selling an estimated $20K and leaving 10,000 shares worth $36.7K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Keystone Financial Group (Kentucky) first reported a position in RXRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $57.3K in Q4 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 10,000 shares of Recursion Pharmaceuticals worth $36.7K as of Q2 2026.
  • Keystone Financial Group (Kentucky) sold 6,000 Recursion Pharmaceuticals shares in Q2 2026, an estimated $20K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #559 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Keystone Financial Group (Kentucky)'s Recursion Pharmaceuticals position peaked at $57.3K in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.